Table 1. Clinical features and demographic characteristics of patients in three groups and comparison of all groups in term of POUR.
| Group I (Placebo) | Group II (Tamsulosin) | Group III (Alfuzosin) | ANOVA F Test (F) or chi-square test (X2) | p value | |
|---|---|---|---|---|---|
| Number of patients | 60 | 60 | 60 | ||
| Mean age±SD (year) | 34.95±15.21 (18-67) | 36.30±15.22 (18-69) | 36.60±15.26 (18-68) | F=0.200 | 0.819 |
| Pre-operative urinary | X2=0.196 | 0.995 | |||
| Symptoms* | 37 (61.6%) | 38 (63.3%) | 39 (65%) | ||
| No | 16 (26.7%) | 15 ( 25%) | 15 (25%) | ||
| Mild Moderate | 7 (11.7%) | 7 (11.7%) | 6 (10%) | ||
| Region of surgery | |||||
| Inguinal | 34 (56.7%) | 36 (60%) | 34 (56.7%) | ||
| Penile | 6 (10%) | 4 (6.7%) | 5 (8.3%) | ||
| Scrotal | 18 (30%) | 19 (31.6%) | 20 (33.3%) | ||
| Perineal | 2 (3.3%) | 1 (1.7%) | 1 (1.7%) | ||
| Mean operation time±SD (minute) | 48.58±12.69 (27-78) | 52.28±13.34 (29-85) | 53.63±13.72 (28-84) | F=2.333 | 0.100 |
| Number of patients with POUR | 15(25%) | 3(5%) | 4(6.7%) | ||
| Comparison of Group I and Group II in term of POUR | X2=9.412 | 0.002 | |||
| Comparison of Group I and Group III in term of POUR | X2=7.566 | 0.006 | |||
| Comparison of Group II and Group III in term of POUR | X2=1.52 | 0.694 | |||
*According to AUA (American Urological Association) symptom score.